Oramed Pharmaceuticals (NASDAQ: ORMP)
Oramed Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Oramed Pharmaceuticals Company Info
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
News & Analysis
Why Oramed Pharmaceuticals Stock Is Crashing Today
The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.
Why Oramed Pharmaceuticals Stock Is On Fire Today
The biotech's stock has been ripping higher of late.
Why Oramed Pharmaceuticals Stock Rocketed Higher Today
A reassuring letter to shareholders has the biotech's stock jumping today.
Oramed Pharmaceuticals: Monday’s Top Stock
Here's why Oramed dominated when the rest of the biotech sector fell today.
Why Oramed Pharmaceuticals, Millennial Media, and Xoom Are Today's 3 Best Stocks
The S&P 500 dips for a third straight session, while Oramed Pharmaceuticals, Millennial Media, and Xoom shares rocketed higher.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.